SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000910627-10-000101
Filing Date
2010-06-01
Accepted
2010-06-01 11:27:59
Documents
1
Effectiveness Date
2010-06-01

Document Format Files

Seq Description Document Type Size
1 genzdfan14a060110.txt DFAN14A 12880
  Complete submission text file 0000910627-10-000101.txt   14993
Mailing Address 500 KENDALL STREET CAMBRIDGE MA 02142
Business Address 500 KENDALL STREET CAMBRIDGE MA 02142 6172527500
GENZYME CORP (Subject) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 000-14680 | Film No.: 10868551
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ICAHN ASSOCIATES CORP. 767 FIFTH AVE., SUITE 4700 NEW YORK NY 10153
Business Address C/O ICAHN ASSOCIATES CORP. 767 FIFTH AVE., SUITE 4700 NEW YORK NY 10153 212-702-4300
ICAHN CARL C (Filed by) CIK: 0000921669 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DFAN14A
SIC: 0000